H Rizk Hanna

Title: H Rizk Hanna: Innovator in Oligosaccharide Glycosides

Introduction

H Rizk Hanna is a notable inventor based in Edmonton, Canada. He holds three patents, showcasing his contributions to the field of oligosaccharide glycosides, particularly with applications in immunosuppressive and tolerogenic properties.

Latest Patents

H Rizk Hanna's latest patents delve into groundbreaking pharmaceutical compositions. One patent discloses novel oligosaccharide glycosides that possess mammalian immunosuppressive and tolerogenic properties. These compositions are designed to modulate cell-mediated immune responses effectively. Another significant patent addresses methods for reducing antigen-induced inflammation in sensitized mammals. This innovation involves oligosaccharide glycosides related to blood group determinants, particularly emphasizing a time-dependent administration strategy that occurs after the initiation of the mammal's immune response.

Career Highlights

Over the years, H Rizk Hanna has made significant strides in his career, working with notable organizations such as the Alberta Research Council and Glycomed, Inc. These experiences have undoubtedly enriched his expertise and facilitated his innovative contributions to the field.

Collaborations

H Rizk Hanna has collaborated with esteemed colleagues, including Robert M Ippolito and Wasimul Haque. Together, they have pushed the boundaries of research and innovation in the field of pharmaceutical sciences.

Conclusion

H Rizk Hanna's dedication to research in oligosaccharide glycosides and their applications highlights his important role as an inventor. His patents address critical issues related to immune response modulation, paving the way for potential advancements in therapeutic strategies. With a robust career and collaborative spirit, Hanna continues to impact the scientific community positively.